Gross, Elena C.
Putananickal, Niveditha
Orsini, Anna-Lena
Schoenen, Jean
Fischer, Dirk
Soto-Mota, Adrian
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (32003B_173193/1)
Article History
Received: 16 January 2022
Accepted: 19 January 2023
First Online: 7 March 2023
Competing interests
: ECG and DF are the inventors of the patent WO 2018/115158 Al held by the UKBB and University of Basel on the use of beta-hydroxybutyrate in migraine prevention. ECG is the founder of KetoSwiss AG. Other authors declare no conflicts of interest.